Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon for Acute Hepatitis C
NCT00241618Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2002
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of peginterferon alfa-2b in hepatitis C virus infection (4 arms), sponsored by Ain Shams University. Primary endpoint: Sustained Viral Response Rate. Started Jan 2002; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00241618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241618.